Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial

Autor: Cuttica, R, Akikusa, J, Chaitow, J, Wouters, C, Oliveira, S, Neiva, CLS, Santiago, M, Silva, CA, Terreri, MT, Magalhaes, C, De Souza, V, Bandeira, M, Chédeville, G, Houghton, K, Vazquez-Del Mercado, M, Rizo Rodriguez, J, Kobusinska, K, Alexeeva, E, Calvo Penades, I, Boteanu, AL, Kasapcopur, O, Poyrazoglu, MH, Erguven, M, Ozen, S, Al-Abadi, E, Bohnsack, J, Carrasco, R, Dare, J, Gottlieb, B, Wahezi, D, Jung, L, Klein-Gitelman, M, Zhang, Y, Wagner-Weiner, L, Tarvin, S, Vehe, RK, Chiraseveenuprapund, P, Rivas-Chacon, R, De La Pena, W, Sagcal-Gironella, ACP, Weiss, JE, Ruperto, Nicolino ^{*, *}, Brunner, Hermine I ^*, Synoverska, Olga, Ting, Tracy V, Mendoza, Carlos Abud, Spindler, Alberto, Vyzhga, Yulia, Marzan, Katherine, Grebenkina, Lyudmila, Tirosh, Irit, Imundo, Lisa, Jerath, Rita, Kingsbury, Daniel J, Sozeri, Betul, Vora, Sheetal S, Prahalad, Sampath, Zholobova, Elena, Butbul Aviel, Yonatan, Chasnyk, Vyacheslav, Lerman, Melissa, Nanda, Kabita, Schmeling, Heinrike, Tory, Heather, Uziel, Yosef, Viola, Diego O, Posner, Holly B, Kanik, Keith S, Wouters, Ann, Chang, Cheng, Zhang, Richard, Lazariciu, Irina, Hsu, Ming-Ann, Suehiro, Ricardo M, Martini, Alberto ^*, Lovell, Daniel J ^*

Publikováno v: In The Lancet 27 November-3 December 2021 398(10315):1984-1996

Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis

Autor: Ruperto N, Brunner HI, Ramanan AV, Horneff G, Cuttica R, Henrickson M, Anton J, Boteanu AL, Penades IC, Minden K, Schmeling H, Hufnagel M, Weiss JE, Pardeo M, Nanda K, Roth J, Rubio-Pérez N, Hsu JC, Wimalasundera S, Wells C, Bharucha K, Douglass W, Bao M, Mallalieu NL, Martini A, Lovell D, De Benedetti F, Paediatric Rheumatology INternational Trials Organisation (PRINTO) and the Pedia

Publikováno v: Rheumatology
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Rheumatology (Oxford, England)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe

OBJECTIVES: To determine s.c. tocilizumab (s.c.-TCZ) dosing regimens for systemic JIA (sJIA) and polyarticular JIA (pJIA). METHODS: In two 52-week phase 1 b trials, s.c.-TCZ (162 mg/dose) was administered to sJIA patients every week or every 2 weeks

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1a314eb0bd4732c03544a4a95918677d
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=18829

The Castilian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)

Autor: de Inocencio, J, Anton, J, Penades, IC, Bermejo, PMD, Alcobendas, R, Boteanu, AL, Bou, R, Iglesias, E, Fernandez, MIG, Montesinos, BL, Santin, P, Rodriguez, PA, Sanchez, MJL, Consolaro, A, Bovis, F, Ruperto, N, Paediat Rheumatology Int Trials

Publikováno v: RHEUMATOLOGY INTERNATIONAL
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

The Juvenile Arthritis Multidimensional Assessment Report (JAMAR) is a new parent/patient reported outcome measure that enables a thorough assessment of the disease status in children with juvenile idiopathic arthritis (JIA). We report the results of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::02d73a93b5386ae179991b132ecb6637
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8898

[OP0208] Diagnostic Value of the Number of Affected Branches of the Temporal Artery by Color Doppler Ultrasonography in Giant Cell Arteritis

Autor: Giraldo, Walter Alberto Sifuentes, Boteanu AL, Rodríguez García A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f1bc64ffc8ec3253cc02d5c521ef7097

Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study.

Autor: Brunner HI; Division of Rheumatology and Department of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio, USA Hermine.brunner@cchmc.org., Akikusa JD; Paediatric Rheumatology Service, The Royal Children's Hospital, Parkville, Victoria, Australia., Al-Abadi E; Paediatric and Adolescent Rheumatology Service, Birmingham Women's and Children's Hospital NHS Foundation Trust, Birmingham, UK., Bohnsack JF; Division of Allergy and Immunology, Primary Children's Hospital, Salt Lake City, Utah, USA., Boteanu AL; Rheumatology Service, Hospital Universitario Ramon y Cajal, Madrid, Spain., Chedeville G; Department of Pediatrics, Division of Rheumatology, McGill University Health Centre, Glen Site, Montreal, Quebec, Canada., Cuttica R; Paediatric Rheumatology, Hospital Britanico de Buenos Aires, Buenos Aires, Argentina., De La Pena W; Pediatric Rheumatology, Loma Linda University Children's Hospital, Loma Linda, California, USA., Jung L; Department of Pediatrics, School of Medicine, George Washington University, Washington, District of Columbia, USA., Kasapcopur O; Department of Paediatric Rheumatology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey., Kobusinska K; Department of Paediatrics, Haematology, Oncology and Rheumatology, Wojewodzki Szpital Dzieciecy im J Brudzinskiego, Bydgoszcz, Poland., Schulert GS; Division of Rheumatology and Department of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Neiva C; Paediatric Rheumatology Network, Santa Casa de Misericórdia de Belo Horizonte, Minas Gerais, Brazil., Rivas-Chacon R; Division of Rheumatology, Nicklaus Children's Hospital, Miami, Florida, USA., Rizo Rodriguez JC; Centro de Alta Especialidad en Reumatología e Investigación del Potosí, SC, San Luis Potosí, Mexico., Vazquez-Del Mercado M; Clínica de Investigacion en Reumatologia y Obesidad, SC, Guadalajara, Mexico., Wagner-Weiner L; Pediatric Rheumatology, University of Chicago Medical Center, Chicago, Illinois, USA., Weiss JE; Pediatric Rheumatology, Hackensack University Medical Center, Hackensack, New Jersey, USA., Wouters C; Paediatric Rheumatology, Department of Paediatrics, UZ Leuven-Gasthuisberg, Leuven, Belgium., Posner H; Pfizer, New York, New York, USA., Wouters A; Pfizer, New York, New York, USA., Chang C; Pfizer, Groton, Connecticut, USA., White C; Pfizer, Walton Oaks, UK., Kanik K; Pfizer, Groton, Connecticut, USA., Liu S; Pfizer, Shanghai, China., Martini A; Paediatric Rheumatology, Department of Paediatrics, University of Genova, Genova, Italy., Lovell DJ; Division of Rheumatology and Department of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Ruperto N; Pediatric and Rheumatology Clinic, IRCCS Istituto Giannina Gaslini, Genova, Italy.

Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2024 Oct 21; Vol. 83 (11), pp. 1561-1571. Date of Electronic Publication: 2024 Oct 21.